Jeffrey McIndoo received a four-month prison sentence, and his company, SARMS Pharm, was ordered to forfeit $1.8 million and shut down. McIndoo must report to prison by January 8, 2027, according to KTAR News.
Terms of the case
KTAR reported that McIndoo pleaded guilty to a misdemeanor drug charge and SARMS Pharm pleaded guilty to a smuggling conspiracy. U.S. District Judge Sharad H. Desai also ordered McIndoo to pay a $1,000 fine and serve one year of supervised release after prison.
The prosecution’s case concerned activity from 2017 through 2022. As described in KTAR’s account, manufacturers in China sent SARMs powder into the United States labeled as other products. At SARMS Pharm’s Phoenix office and warehouse, some of the powder was made into injectable liquids for shipment to customers around the country. Prosecutors estimated that sales of the unapproved products brought in at least $3.5 million.
KTAR also reported that an undercover federal agent bought products from the company in 2021. Prosecutors said employees opened bank accounts using names other than the company’s to hinder law enforcement efforts to seize its funds.
What regulators say about SARMs
The FDA says SARMs are not approved and may be marketed as supplements or for research use despite being unapproved drugs that cannot legally be marketed in the United States as supplements or drugs. The agency says it has sent warning letters to companies selling unapproved SARMs products and pursued criminal cases against distributors, as described in its guidance on bodybuilding products.
